CHIMERA: a phase II study of neoadjuvant pembrolizumab in combination with cisplatin or carboplatin and pemetrexed followed by surgery and adjuvant pembrolizumab in resectable pleural mesothelioma

SSRN Electronic Journal 2026 Preprint Open access

Read full text
Authors: Giulia Pasello, Daniela Scattolin, Eleonora Faccioli, Paolo Andrea Zucali, Giuseppe Marulli, Federica Grosso, Giovanni Luca Ceresoli, Marcello Tiseo, Alessandra Bearz, Fabiana Letizia Cecere, Luana Calabrò, Francesco Callegarin
+7 more Paola Del Bianco, Gian Luca De Salvo, Federica Pezzuto, Fiorella Calabrese, Valentina Guarneri, Andrea Dell'Amore, Federico Rea
DOI: 10.2139/ssrn.6000019
Cited by: 0

Fields of Study & Subjects

Occupational and environmental lung diseases Pleural and Pulmonary Diseases Cancer Immunotherapy and Biomarkers

Publication details

Journal / source
SSRN Electronic Journal
Publication date
1 January 2026
Document type
Preprint